CytRx Corporation (CYTR) Reports 2014 Second Quarter Financial Results
8/6/2014 9:21:07 AM
CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended June 30, 2014, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs.
“We advanced the aldoxorubicin program in the second quarter of 2014 with important data presentations at AACR and ASCO, two of the most significant medical meetings in oncology,” said Steven A. Kriegsman, CytRx President and CEO.
Help employers find you! Check out all the jobs and post your resume.
comments powered by